Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine eye drops for inhibition of myopic progression
IRCT20100414003714N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atropine in myopia (3 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Percent change in myopic power and Change in axial length. Started Jun 2018; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on IRCT20100414003714N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100414003714N3.